Drug Addiction Treatment Reaches a New Level: Israeli Doctors Eliminate Opioid Cravings in a Single Session
In a first for the country, Rambam Medical Center in Haifa, Israel, has successfully utilized an innovative, non-invasive technology to treat severe opioid use disorder. A patient suffering from severe dependency was relieved of overwhelming drug cravings after just one brief procedure.
The pioneering method relies on MRI-guided focused ultrasound (MRgFUS) technology, developed by the Israeli medical device company InSightec. The patient is fitted with a highly specialized, high-tech helmet equipped with hundreds of ultrasound transducers. These sound waves pass harmlessly through tissue, converging on a precise focal point deep within the brain. This targeted concentration of energy facilitates neuromodulation—altering the activity of specific neural pathways without physically destroying them. The entire process is performed under continuous, real-time MRI guidance to ensure absolute precision.
Medical teams targeted the *nucleus accumbens*, a critical component of the brain’s dopamine reward system that drives pathological habit formation and compulsive substance-seeking behavior. By modulating the neural connectivity in this specific region, doctors were able to break the physiological cycle of addiction.
According to specialists at Rambam, the patient experienced a noticeable reduction in cravings during the roughly 20-minute session itself. In the days following the procedure, the urge to use completely vanished, and subsequent toxicological tests confirmed the absence of opioids and other substances in the patient’s system. The patient also reported a profound improvement in their overall well-being.
This landmark procedure was conducted as part of an international clinical trial. While similar approaches have been tested at leading medical centers in the United States, Rambam is the first institution outside of America to successfully apply InSightec’s technology for addiction treatment. While the technology is already widely recognized for treating essential tremor and Parkinson’s disease symptoms, its expansion into psychiatry and addiction medicine represents a significant paradigm shift.
Physicians emphasize that the non-invasive method is highly tolerable and boasts a robust safety profile. It holds the potential to become a crucial adjunct to standard rehabilitation programs, particularly for patients with severe, treatment-resistant forms of addiction.
This breakthrough at Rambam further cements Israel’s position at the forefront of advanced medical technology, offering new hope to millions struggling with the opioid crisis worldwide. Ongoing research will evaluate the method’s long-term efficacy and explore its potential applications for other psychiatric and neurological conditions.
